Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
The American Journal of Medicine|April 20, 2004
Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugsGeorge V Papatheodoridis, Despina Papadelli, Evangelos Cholongitas, et al.The American Journal of Gastroenterology|October 24, 2003
Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infectionEmanuel K Manesis, George V Papatheodoridis, Vasilios Sevastianos, et al.Scandinavian Journal of Gastroenterology|March 1, 2007
Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirinGraham R Foster, Michael W Fried, Stephanos J Hadziyannis, et al.Journal of Medical Virology|May 14, 2011
Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis BEvangelos Cholongitas, George V Papatheodoridis, Emanuel K Manesis, et al.Journal of Hepatology|April 14, 2010
Definition of rapid virologic response with a highly sensitive real-time PCR-based HCV RNA assay in peginterferon alfa-2a plus ribavirin response-guided therapyChristoph Sarrazin, Mitchell L Shiffman, Stephanos J Hadziyannis, et al.Hepatology (Baltimore, Md.)|November 18, 2009
Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosisSavino Bruno, Mitchell L Shiffman, Stuart K Roberts, et al.Journal of Hepatology|July 23, 2013
Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: on-treatment kinetics of HBsAg serum levels vary by HBV genotypeMaurizia R Brunetto, Patrick Marcellin, Beatrice Cherubini, et al.Hepatology (Baltimore, Md.)|June 18, 2005
Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudineGeorge V Papatheodoridis, Evangelini Dimou, Konstantinos Dimakopoulos, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 1, 2007
Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirinEric Snoeck, Stephanos J Hadziyannis, Claudio Puoti, et al.Kidney International|August 26, 2004
Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studiesHassane Izzedine, Jean Sebastien Hulot, Vincent Launay-Vacher, et al.Pageof 5